{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T15:34:27Z","timestamp":1766504067274,"version":"build-2065373602"},"reference-count":82,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatriconcology.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.jgo.2020.02.005","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T08:12:51Z","timestamp":1583309571000},"page":"917-925","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The challenge of avoiding over- and under-treatment in older women with ductal cancer in situ: A scoping review of existing knowledge gaps and a meta-analysis of real-world practice patterns"],"prefix":"10.1016","volume":"11","author":[{"given":"Andreas","family":"Karakatsanis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Markopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9169","key":"10.1016\/j.jgo.2020.02.005_bb0005","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(99)05036-9","article-title":"Tamoxifen in treatment of intraductal breast cancer: national surgical adjuvant breast and bowel project B-24 randomised controlled trial","volume":"353","author":"Fisher","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jgo.2020.02.005_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2010.03.017","article-title":"Mammographic screening for breast cancer: an invited review of the benefits and costs","author":"Greif","year":"2010","journal-title":"Breast"},{"key":"10.1016\/j.jgo.2020.02.005_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(11)70383-7","article-title":"Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)","author":"Biganzoli","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jgo.2020.02.005_bb0020","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2003.02.046","article-title":"Undertreatment strongly decreases prognosis of breast cancer in elderly women","author":"Bouchardy","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2020.02.005_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jgo.2020.02.005_bb0030","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"year":"2014","series-title":"Version 5.3","author":"Review Manager (RevMan) [Computer program]","key":"10.1016\/j.jgo.2020.02.005_bb0035"},{"key":"10.1016\/j.jgo.2020.02.005_bb0040","doi-asserted-by":"crossref","unstructured":"Wells G, Shea B, O'\u2019Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. (Available from URL http:\/\/www.Ohri.ca\/Programs\/Clinical_epidemiology\/Oxford.Asp) 2012. doi:10.2307\/632432.","DOI":"10.2307\/632432"},{"key":"10.1016\/j.jgo.2020.02.005_bb0045","doi-asserted-by":"crossref","DOI":"10.1007\/s10549-017-4330-5","article-title":"Incidence and treatments of DCIS in octogenarians: grade matters","author":"Ward","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jgo.2020.02.005_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2019.02.034","article-title":"Surgery and adjuvant radiotherapy for unilateral ductal carcinoma in situ (DCIS) in women aged over 70 years: a population based cohort study","author":"Jauhari","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jgo.2020.02.005_bb0055","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2015.0876","article-title":"Survival benefit of breast surgery for low-grade ductal carcinoma in situ a population-based cohort study","author":"Sagara","year":"2015","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jgo.2020.02.005_bb0060","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2009.25.9796","article-title":"Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival","author":"Schonberg","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2020.02.005_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/bjs.10885","article-title":"Omission of surgery in older women with early breast cancer has an adverse impact on breast cancer-specific survival","author":"Ward","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.jgo.2020.02.005_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2015.12.012","article-title":"The use of surgery in the treatment of ER+ early stage breast cancer in England: variation by time, age and patient characteristics","author":"Richards","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jgo.2020.02.005_bb0075","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-007-9708-x","article-title":"The influence of age on the breast surgery decision-making process","author":"Bleicher","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jgo.2020.02.005_bb0080","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdz173","article-title":"Early breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up\u2020","author":"Cardoso","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jgo.2020.02.005_bb0085","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1200\/JCO.2018.78.0270","article-title":"Limitations in the effect of screening on breast cancer mortality","volume":"36","author":"Beau","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2020.02.005_bb0090","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.11110469","article-title":"Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades","author":"Tab\u00e1r","year":"2011","journal-title":"Radiology"},{"year":"2014","series-title":"National Guidelines on the Diagnosis, Treatment and Follow-up of Breast Cancer","key":"10.1016\/j.jgo.2020.02.005_bb0095"},{"author":"Netherlands","key":"10.1016\/j.jgo.2020.02.005_bb0100"},{"author":"American Cancer Society","key":"10.1016\/j.jgo.2020.02.005_bb0105"},{"author":"Life expectancy calculators","key":"10.1016\/j.jgo.2020.02.005_bb0110"},{"key":"10.1016\/j.jgo.2020.02.005_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bjc.6604968","article-title":"Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French survey experience","author":"Cutuli","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jgo.2020.02.005_bb0120","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.breast.2014.08.013","article-title":"Risk of subsequent invasive breast cancer after a diagnosis of ductal carcinoma in situ (DCIS)","volume":"23","author":"Cheung","year":"2014","journal-title":"Breast"},{"key":"10.1016\/j.jgo.2020.02.005_bb0125","doi-asserted-by":"crossref","DOI":"10.1097\/CEJ.0000000000000131","article-title":"Predictors for local invasive recurrence of ductal carcinoma in situ of the breast: a meta-analysis","author":"Zhang","year":"2016","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.jgo.2020.02.005_bb0130","doi-asserted-by":"crossref","DOI":"10.1007\/s10549-015-3472-6","article-title":"Characteristics and behaviour of screen-detected ductal carcinoma in situ of the breast: comparison with symptomatic patients","author":"Koh","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jgo.2020.02.005_bb0135","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-017-0819-4","article-title":"The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study","author":"Elshof","year":"2017","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.jgo.2020.02.005_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2018.08.094","article-title":"Local recurrence outcomes after breast conserving surgery and adjuvant radiotherapy in ductal carcinoma in situ of the breast and a comparison with ECOG E5194 study","author":"Ozkaya Akagunduz","year":"2018","journal-title":"Breast"},{"key":"10.1016\/j.jgo.2020.02.005_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2018.07.007","article-title":"Breast-conserving therapy for primary ductal carcinoma in situ in the Netherlands: a multi-center study and population-based analysis","author":"Jobsen","year":"2018","journal-title":"Breast"},{"key":"10.1016\/j.jgo.2020.02.005_bb0150","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djr027","article-title":"Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS","author":"Wapnir","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jgo.2020.02.005_bb0155","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-010-1441-1","article-title":"Ductal carcinoma in situ of the breast: Influence of age on diagnostic, therapeutic, and prognostic features. Retrospective study of 812 patients","author":"Tunon-De-Lara","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jgo.2020.02.005_bb0160","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2015.60.8588","article-title":"Surgical excision without radiation for ductal carcinoma in situ of the breast: 12-year results from the ECOG-ACRIN E5194 study","author":"Solin","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2020.02.005_bb0165","article-title":"Age at diagnosis predicts local recurrence in women treated with breast-conserving surgery and postoperative radiation therapy for ductal carcinoma in situ: a population-based outcomes analysis","author":"Kong","year":"2014","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jgo.2020.02.005_bb0170","doi-asserted-by":"crossref","DOI":"10.1111\/tbj.12127","article-title":"Long-term impact of young age at diagnosis on treatment outcome and patterns of failure in patients with ductal carcinoma in situ treated with breast-conserving therapy","author":"Vicini","year":"2013","journal-title":"Breast J"},{"key":"10.1016\/j.jgo.2020.02.005_bb0175","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-016-5249-5","article-title":"Impact of age on risk of recurrence of ductal carcinoma in situ: outcomes of 2996 women treated with breast-conserving surgery over 30 years","author":"Cronin","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jgo.2020.02.005_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.11204","article-title":"Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women","author":"Rodrigues","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.jgo.2020.02.005_bb0185","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-012-2413-4","article-title":"Biology, treatment, and outcome in very young and older women with DCIS","author":"Alvarado","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jgo.2020.02.005_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2010.07.005","article-title":"The effect of age in the outcome and treatment of older women with ductal carcinoma in situ","author":"Ho","year":"2011","journal-title":"Breast"},{"key":"10.1016\/j.jgo.2020.02.005_bb0195","doi-asserted-by":"crossref","DOI":"10.1002\/jso.1041","article-title":"Relationship between excision volume, margin status, and tumor size with the development of local recurrence in patients with ductal carcinoma-in-situ treated with breast-conserving therapy","author":"Vicini","year":"2001","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jgo.2020.02.005_bb0200","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2007.13.9121","article-title":"Multifocal ductal carcinoma in situ of the breast: a contraindication for breast-conserving treatment?","author":"Meijnen","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2020.02.005_bb0205","doi-asserted-by":"crossref","DOI":"10.1158\/1055-9965.EPI-18-0976","article-title":"Predictors of an invasive breast cancer recurrence after DCIS: a systematic review and meta-analyses","author":"Visser","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jgo.2020.02.005_bb0210","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-010-1214-x","article-title":"Predictors of local recurrence in a population-based cohort of women with ductal carcinoma in situ treated with breast conserving surgery alone","author":"Wai","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.jgo.2020.02.005_bb0215","first-page":"495","article-title":"Risk factors for subsequent invasive breast cancer and breast cancer death after ductal carcinoma in situ: a population-based case-control study in Sweden","volume":"10","author":"W\u00e4rnberg","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jgo.2020.02.005_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2003.11.004","article-title":"High nuclear grade and negative estrogen receptor are significant risk factors for recurrence in DCIS","author":"Roka","year":"2004","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jgo.2020.02.005_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2016.07.023","article-title":"Clinical-pathological features and treatment modalities associated with recurrence in DCIS and micro-invasive carcinoma: who to treat more and who to treat less","author":"Toss","year":"2016","journal-title":"Breast"},{"key":"10.1016\/j.jgo.2020.02.005_bb0230","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdv062","article-title":"Molecular phenotypes of DCIS predict overall and invasive recurrence","author":"Williams","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jgo.2020.02.005_bb0235","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-13-512","article-title":"Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study","author":"Zhou","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jgo.2020.02.005_bb0240","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdv013","article-title":"Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ","author":"Curigliano","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jgo.2020.02.005_bb0245","doi-asserted-by":"crossref","DOI":"10.1038\/bjc.2012.41","article-title":"HER2\/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ","author":"Rakovitch","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jgo.2020.02.005_bb0250","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2015.2510","article-title":"Breast cancer mortality after a diagnosis of ductal carcinoma in situ","author":"Narod","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jgo.2020.02.005_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/bjs.10589","article-title":"Risk of death from breast cancer after treatment for ductal carcinoma in situ","author":"Wadsten","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.jgo.2020.02.005_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2018.06.027","article-title":"Management and 5-year outcomes in 9938 women with screen-detected ductal carcinoma in situ: the UK Sloane project","author":"Thompson","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jgo.2020.02.005_bb0265","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.21069","article-title":"The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up","author":"Sanders","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.jgo.2020.02.005_bb0270","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djy220","article-title":"Cancer outcomes in DCIS patients without locoregional treatment","author":"Ryser","year":"2019","journal-title":"JNCI J Natl Cancer Inst"},{"key":"10.1016\/j.jgo.2020.02.005_bb0275","unstructured":"The LORD trial (\u2018\u201cLOw Risk DCIS\u201d)\u2019 2019, https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02492607. Last update March 8, 2019"},{"year":"2014","series-title":"The LORIS Trial (A Phase III Trial of Surgery Versus Active Monitoring) for LOw RISk DCIS","key":"10.1016\/j.jgo.2020.02.005_bb0280"},{"key":"10.1016\/j.jgo.2020.02.005_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2017.07.012","article-title":"Current trials to reduce surgical intervention in ductal carcinoma in situ of the breast: critical review","author":"Toss","year":"2017","journal-title":"Breast"},{"key":"10.1016\/j.jgo.2020.02.005_bb0295","article-title":"Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast","author":"Davidson","year":"2010","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.jgo.2020.02.005_bb0300","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2013.49.5077","article-title":"Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial","author":"Donker","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2020.02.005_bb0305","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2014.56.2595","article-title":"Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS trial","author":"W\u00e4rnberg","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2020.02.005_bb0310","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2014.57.9029","article-title":"RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation","author":"McCormick","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2020.02.005_bb0315","doi-asserted-by":"crossref","DOI":"10.1007\/s10549-018-4803-1","article-title":"Risk of ischemic heart disease after radiotherapy for ductal carcinoma in situ","author":"Wadsten","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jgo.2020.02.005_bb0320","article-title":"Cardiovascular morbidity and mortality in patients treated for ductal carcinoma in situ of the breast","author":"Boekel","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2020.02.005_bb0325","doi-asserted-by":"crossref","DOI":"10.1111\/tbj.12368","article-title":"Treatment selection for patients with ductal carcinoma in situ (DCIS) of the breast using the University of Southern California\/Van Nuys (USC\/VNPI) Prognostic Index","author":"Silverstein","year":"2015","journal-title":"Breast J"},{"key":"10.1016\/j.jgo.2020.02.005_bb0330","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2015.65.1869","article-title":"Patient prognostic score and associations with survival improvement offered by radiotherapy after breast-conserving surgery for ductal carcinoma in situ: a population-based longitudinal cohort study","author":"Sagara","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2020.02.005_bb0335","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw256","article-title":"Multigene expression assay and benefit of radiotherapy after breast conservation in ductal carcinoma in situ","author":"Rakovitch","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jgo.2020.02.005_bb0340","doi-asserted-by":"crossref","DOI":"10.1007\/s10549-018-4693-2","article-title":"Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies","author":"Rakovitch","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jgo.2020.02.005_bb0345","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-18-0842","article-title":"A biological signature for breast ductal carcinoma in situ to predict radiotherapy benefit and assess recurrence risk","author":"Bremer","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jgo.2020.02.005_bb0350","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2010.34.0141","article-title":"Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24","author":"Allred","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2020.02.005_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(10)70266-7","article-title":"Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK\/ANZ DCIS trial","author":"Cuzick","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jgo.2020.02.005_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(15)01129-0","article-title":"Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial","author":"Forbes","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jgo.2020.02.005_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2014.06.015","article-title":"Postoperative Tamoxifen for ductal carcinoma in situ: Cochrane systematic review and meta-analysis","author":"Staley","year":"2014","journal-title":"Breast"},{"key":"10.1016\/j.jgo.2020.02.005_bb0370","article-title":"Breast cancer screening in Denmark: a cohort study of tumor size and overdiagnosis","author":"J\u00f8rgensen","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jgo.2020.02.005_bb0375","article-title":"The benefits and harms of breast cancer screening: an independent review","author":"Marmot","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jgo.2020.02.005_bb0380","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv103","article-title":"Benefits and harms of mammography screening after age 74 years: model estimates of Overdiagnosis","author":"Van Ravesteyn","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jgo.2020.02.005_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(08)60342-6","article-title":"Complex interventions to improve physical function and maintain independent living in elderly people: a systematic review and meta-analysis","author":"Beswick","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jgo.2020.02.005_bb0390","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006211.pub3","article-title":"Comprehensive geriatric assessment for older adults admitted to hospital","author":"Ellis","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgo.2020.02.005_bb0395","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afw039","article-title":"Development and validation of an electronic frailty index using routine primary care electronic health record data","author":"Clegg","year":"2016","journal-title":"Age Ageing"},{"author":"No Title","key":"10.1016\/j.jgo.2020.02.005_bb0400"},{"key":"10.1016\/j.jgo.2020.02.005_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2017.01.012","article-title":"What influences healthcare professionals\u2019 treatment preferences for older women with operable breast cancer? An application of the discrete choice experiment","author":"Morgan","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jgo.2020.02.005_bb0410","doi-asserted-by":"crossref","DOI":"10.1002\/pon.4429","article-title":"Information needs and decision-making preferences of older women offered a choice between surgery and primary endocrine therapy for early breast cancer","author":"Burton","year":"2017","journal-title":"Psychooncology"},{"key":"10.1016\/j.jgo.2020.02.005_bb0415","doi-asserted-by":"crossref","DOI":"10.1007\/s10549-018-4865-0","article-title":"Patient-reported factors influencing the treatment decision-making process of older women with non-metastatic breast cancer: a systematic review of qualitative evidence","author":"Angarita","year":"2018","journal-title":"Breast Cancer Res Treat"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406819304084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406819304084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:50:57Z","timestamp":1761817857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406819304084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":82,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1879406819304084"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2020.02.005","relation":{},"ISSN":["1879-4068"],"issn-type":[{"type":"print","value":"1879-4068"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The challenge of avoiding over- and under-treatment in older women with ductal cancer in situ: A scoping review of existing knowledge gaps and a meta-analysis of real-world practice patterns","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2020.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}